ec 27 has been researched along with angiotensin ii in 3 studies
| Studies (ec 27) | Trials (ec 27) | Recent Studies (post-2010) (ec 27) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | ec 27 (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chauvel, E; Corvol, P; Fournie-Zaluski, MC; Llorens-Cortes, C; Roques, BP; Zini, S | 1 |
| Llorens-Cortes, C | 1 |
| Corvol, P; David, C; Fassot, C; Fournie-Zaluski, MC; Iturrioz, X; Llorens-Cortes, C; Maigret, B; Reaux, A; Roques, BP; Rozenfeld, R | 1 |
3 other study(ies) available for ec 27 and angiotensin ii
| Article | Year |
|---|---|
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Topics: Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Injections, Intraventricular; Kinetics; Male; Mice; Protease Inhibitors; Saralasin; Substrate Specificity; Sulfhydryl Compounds; Sulfonic Acids; Time Factors; Vasopressins | 1996 |
[Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion].
Topics: Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Brain; CD13 Antigens; Cerebral Ventricles; Glutamyl Aminopeptidase; Half-Life; Hypothalamus; Injections, Intraventricular; Male; Mice; Protease Inhibitors; Saralasin; Sulfhydryl Compounds; Sulfonic Acids; Vasopressins | 1998 |
Aminopeptidase A, generating one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, plays a key role in central control of blood pressure.
Topics: Angiotensin II; Angiotensin III; Animals; Binding Sites; Blood Pressure; Brain Chemistry; CD13 Antigens; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Glutamyl Aminopeptidase; Humans; Male; Methionine; Mice; Models, Molecular; Mutagenesis, Site-Directed; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Sulfhydryl Compounds; Sulfonic Acids | 2003 |